Can You Take Senokot With Mounjaro?

Why does Mounjaro cause constipation in the first place?

Tirzepatide slows gastric emptying, food moves through your stomach and intestines more gradually than before. That is largely how the medicine reduces appetite and helps you feel full for longer. The downside is that slower transit through the gut can allow more water to be absorbed from stool, making it harder and more difficult to pass.

The Mounjaro overview page covers the dual GIP and GLP-1 mechanism in more detail, but from a practical standpoint the important thing to know is that constipation tends to be most noticeable early in treatment and after each dose step up. For most people it eases once the body adjusts, usually within a few weeks. If you are finding the adjustment difficult, you are far from alone, it is among the questions our prescribers hear most regularly.

Hydration matters more than it might seem here. When gut transit slows, even mild dehydration compounds the problem. Adequate fluid intake and a diet with enough fibre form the sensible first line before reaching for anything else. The NHS patient information page for tirzepatide lists constipation among the common side effects and suggests dietary measures as the first step.

Is senna safe to take alongside tirzepatide?

Senna is a stimulant laxative derived from the leaves and pods of the Senna plant. It works by stimulating the muscle in the bowel wall to contract, pushing contents along. Critically, it acts locally in the colon and is not absorbed into the systemic circulation in amounts that would interact with a subcutaneously injected medicine like tirzepatide.

There is no documented pharmacokinetic interaction between senna and tirzepatide. The pharmacokinetics of tirzepatide page explains how the medicine is absorbed and cleared, nothing in that pathway crosses with the mechanism of a bowel-acting stimulant laxative. Senokot's standard formulations (tablets and syrup) contain senna as their sole active ingredient, so the same reasoning applies to them specifically.

One practical note: stimulant laxatives like senna are generally recommended for short-term use rather than as a daily habit. If you find you need them regularly throughout treatment, that is worth raising with your prescriber. It may point to a dietary adjustment, a hydration gap, or a titration consideration rather than ongoing laxative use.

If your constipation is bound up with an underlying condition such as IBS, the picture is a little more individual and worth a direct conversation with your clinical team.

Are there other bowel-related medicines to think about on Mounjaro?

Senna is not the only option for constipation management, and different laxative types suit different situations. Osmotic laxatives (such as lactulose or macrogol) work by drawing water into the bowel rather than stimulating muscle contractions, they are often preferred for longer-term use. Bulk-forming laxatives (such as ispaghula husk) increase stool volume and generally suit people who need ongoing support. None of these interact meaningfully with tirzepatide either, but your pharmacist or prescriber is best placed to recommend which type fits your situation.

A separate and more specific point: the page on taking senna alongside Mounjaro goes into the ingredient-level detail if you want to compare formulations. Some branded laxatives combine senna with other actives (such as docusate), so if you are using a combination product, it is worth checking the label.

Other medicines that affect gut motility can also be relevant alongside Mounjaro. Anything that further slows or speeds transit could compound or counteract tirzepatide's own effect on gastric emptying. If you are also on other prescribed medicines that touch gut function, the page on taking other GLP-1 medicines alongside Mounjaro touches on interaction considerations more broadly, and your prescriber holds the full picture of your medication list.

When should you speak to a prescriber about constipation on Mounjaro?

Most constipation on tirzepatide resolves without medical input. A few situations do warrant a call to your clinical team. Severe, persistent abdominal pain (especially pain that radiates to the back) should be reported promptly, as the MHRA's January 2026 Drug Safety Update flagged acute pancreatitis as an infrequent but serious consideration with GLP-1 medicines; that symptom pattern is distinct from ordinary constipation but should not be ignored.

Constipation lasting more than a week despite dietary changes and over-the-counter support, or constipation accompanied by bloating, nausea, or vomiting that is significantly worse than your baseline, also merits a conversation. Your prescriber may consider adjusting the pace of dose titration or suggesting a specific laxative regimen rather than leaving it to trial and error.

There are also some interactions to be aware of in the broader picture of medicines you might be taking alongside Mounjaro. If you use HRT, for instance, the page on Mounjaro and HRT covers the absorption considerations that are specific to that combination. And if you are unwell (a stomach bug on top of constipation, say) the Mounjaro and illness page explains when to pause and when to carry on.

If you are considering starting tirzepatide and want to understand how our prescribers approach these practical questions from day one, you can read about the clinical approach at nume or speak to our prescribers through a free consultation.